Advertisement

Studies with Hematoporphyrin Derivative in Transplantable Urothelial Tumors

  • M. Kreimer-Birnbaum
  • J. E. Klaunig
  • R. Keck
  • P. J. Goldblatt
  • S. L. Britton
  • S. H. Selman

Abstract

HpD is a mixture of dicarboxylic porphyrins with tumor localizing as well as photosensitizing properties. The active component(s) of HpD and the alkali solubilized HpD, hereafter referred to as HpD (Inj.), have been under intense study in many laboratories (general ref.: Kessel and Dougherty, 1983).

Keywords

Transitional Cell Carcinoma Transplantable Tumor Urothelial Tumor Hematoporphyrin Derivative Radioactive Microsphere 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Bonnett, R., Ridge, R. J., Scourides, P. A., and Berenbaum, M. C., 1981, On the nature of ‘haematoporphyrin derivative.’ J. Chenu Soc. Perkin Trans. I 37:3135.CrossRefGoogle Scholar
  2. Bugelski, P. J., Porter, C. W., and Dougherty, T. J., 1981, Autoradiographic distribution of hematoporphyrin derivative in normal and tumor tissue of the mouse, Cancer Res. 41:4606.Google Scholar
  3. Cadby, P. A., Dimitriadis, E., Grant, H. G., Ward, A. D., and Forbes, I. J., 1982, Separation and analysis of haematoporphyrin derivative components by high-performance liquid chromatography, J. Chromatogr. 231:273.CrossRefGoogle Scholar
  4. Chang, C. T., and Dougherty, T. J., 1978, Photoradiation therapy: kinetics and thermodynamics of porphyrin uptake and loss in normal and malignant cells in culture, Radiat. Res. 74:498.Google Scholar
  5. Dougherty, T. J., Boyle, D. G., Weishaupt, K. R., Henderson, B. A., Potter, W. R., Bellnier, D. A., and Wityk, K. E., 1983, Photoradiation therapy — clinical and drug advances, in: “Porphyrin Photosensitization,” D. Kessel and T. J. Dougherty, eds., Plenum Press, New York.Google Scholar
  6. Dougherty, T. J., Kaufman, J. E., Goldfarb, A., Weishaupt, K. R. , Boyle, D., and Mittelman, A., 1978, Photoradiation therapy for the treatment of malignant tumors, Cancer Res. 38:2628.Google Scholar
  7. Dougherty, T. J., 1982, Variability in hematoporphyrin derivative preparations, Cancer Res. 42:1188.Google Scholar
  8. Ellfolk, N., and Sievers, G., 1966, Thin layer chromatography of free porphyrins, J. Chromatogr. 25:373.CrossRefGoogle Scholar
  9. Henderson, R. W., Bellnier, D. A., Ziring, B., and Dougherty, T. J., 1983, Aspects of the cellular uptake and retention of hematoporphyrin derivative and their correlation with the biological response to PRT in vitro, in: “Porphyrin Photosensitization,” Plenum Press, New York.Google Scholar
  10. Henderson, R. W., Christie, G. S., Clezy, P. S., and Lineham, J., 1980, Haematoporphyrin diacetate: a probe to distinguish malignant from normal tissue by selective fluorescence, Brit. J Exper. Pathol. 61:345.Google Scholar
  11. Kessel, D., 1982, Components of hematoporphyrin derivatives and their tumor-localizing capacity, Cancer Res. 42:1703.Google Scholar
  12. Kessel, D., and Dougherty, T. J., 1983, “Porphyrin Photosensitization,” Plenum Press, New York.Google Scholar
  13. Kreimer-Birnbaum, M., Baumann, J. L., Klaunig, J. E., Keck, R., Goldblatt, P. J., and Selman, S. H., 1983, Chemical studies with hematoporphyrin derivative in bladder cell lines, in: “Clayton Symposium on Porphyrin Localization and Treatment of Tumors,” D. R. Doiron and C. J. Gomer, eds. , Alan R. Liss, New York, in press.Google Scholar
  14. Lowry, O. H., Rosebrough, A., Farr, A. L., and Randall, R. J., 1951, Protein measurement with the Folin phenol reagent, J. Biol. Chem. 193:265.Google Scholar
  15. Moan, J., McGhie, J. B., and Christensen, T., 1982, Hematoporphyrin derivative: photosensitizing efficiency and cellular uptake of its components, Photobiochem. Photobiophys. 4:337.Google Scholar
  16. Moan, J., Steen, H. B., Feren, K., and Christensen, T., 1981, Uptake of hematoporphyrin derivative and sensitized photoinactivation of C3H cells with different oncogenic potential, Cancer Lett. 14:291.CrossRefGoogle Scholar
  17. Mossman, B. T., Gray, M. J., Silberman, L., and Lipson, L., 1974, Identification of neoplastic versus normal cells in human cervical cell culture, J. Obstet. Gynaecol. 43:635.Google Scholar
  18. Selman, S. H., Keck, R., Klaunig, J. E., Kreimer-Birnbaum, M., Goldblatt, P. J., and Britton, S. L., 1983, Acute blood flow changes in transplantable FANFT-induced urothelial tumors treated with hematoporphyrin derivative and light, Surgical Forum, in press.Google Scholar

Copyright information

© Plenum Press, New York 1984

Authors and Affiliations

  • M. Kreimer-Birnbaum
    • 1
    • 5
  • J. E. Klaunig
    • 2
  • R. Keck
    • 3
  • P. J. Goldblatt
    • 2
  • S. L. Britton
    • 4
  • S. H. Selman
    • 3
  1. 1.Research Department and Porphyrin LaboratorySt. Vincent Hospital and Medical CenterToledoUSA
  2. 2.Department of PathologyMedical College of OhioToledoUSA
  3. 3.Department of Surgery (Div. of Urology)Medical College of OhioToledoUSA
  4. 4.Department of PhysiologyMedical College of OhioToledoUSA
  5. 5.Department of BiochemistryMedical College of OhioToledoUSA

Personalised recommendations